Dysregulated Wnt and NFAT signaling in a Parkinson’s disease LRRK2 G2019S knock-in model
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Dysregulated Wnt and NFAT signaling in a Parkinson’s disease LRRK2 G2019S knock-in model ; volume:14 ; number:1 ; day:29 ; month:5 ; year:2024 ; pages:1-22 ; date:12.2024
Scientific reports ; 14, Heft 1 (29.5.2024), 1-22, 12.2024
- Urheber
-
Wetzel, Andrea
Lei, Si Hang
Liu, Tiansheng
Hughes, Michael P.
Peng, Yunan
McKay, Tristan
Waddington, Simon N.
Grannò, Simone
Rahim, Ahad A.
Harvey, Kirsten
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-63130-8
- URN
-
urn:nbn:de:101:1-2408062122226.687047414337
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wetzel, Andrea
- Lei, Si Hang
- Liu, Tiansheng
- Hughes, Michael P.
- Peng, Yunan
- McKay, Tristan
- Waddington, Simon N.
- Grannò, Simone
- Rahim, Ahad A.
- Harvey, Kirsten
- SpringerLink (Online service)
Ähnliche Objekte (12)
LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
Pathogenic Mutation of Lrrk2 : A Mouse Model for pre-motor Parkinson’s disease
Lysosomal Pathogenesis of Parkinson’s Disease: Insights From LRRK2 and GBA1 Rodent Models
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
Pathogenic Mutation of Lrrk2 : A Mouse Model for pre-motor Parkinson’s disease
Lysosomal Pathogenesis of Parkinson’s Disease: Insights From LRRK2 and GBA1 Rodent Models
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
Pathogenic Mutation of Lrrk2 : A Mouse Model for pre-motor Parkinson’s disease
Lysosomal Pathogenesis of Parkinson’s Disease: Insights From LRRK2 and GBA1 Rodent Models